Health-related Google searches are increasing year after year, showing that consumers are interested in knowing more about their health conditions and how to manage them. This might pose D2C as a reasonable market strategy for digital health companies. The fact that we have seen Digital Health companies shifting from the traditional pharma pathway towards D2C, also reveals the potential of this route to market, which can help to gain traction faster and make the business more scalable. Join this meeting where we will have an informal conversation on:
-Therapeutic areas more suited to use D2C strategies
-There are companies that use D2C as an additional route to market to payers, employers, etc. What do these blended routes to market look like?